ROYAL BANK OF CANADA - SATSUMA PHARMACEUTICALS INC ownership

SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 46 filers reported holding SATSUMA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SATSUMA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$0
-100.0%
93
-94.8%
0.00%
Q2 2021$13,000
+85.7%
1,774
+43.5%
0.00%
Q1 2021$7,000
+40.0%
1,236
+25.2%
0.00%
Q4 2020$5,000987
+8125.0%
0.00%
Q2 2020$0
-100.0%
12
-96.3%
0.00%
Q1 2020$6,0000.0%321
+6.6%
0.00%
Q4 2019$6,0003010.00%
Other shareholders
SATSUMA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Alambic Investment Management, L.P. 20,711$81,0000.89%
RA Capital Management 4,681,858$18,212,0000.33%
Ghost Tree Capital, LLC 200,000$778,0000.22%
TPG Group Holdings (SBS) Advisors, Inc. 1,885,939$7,336,0000.13%
Virtu Financial LLC 39,062$152,0000.03%
Quantitative Systematic Strategies LLC 14,195$55,0000.01%
Cetera Advisor Networks LLC 85,000$331,0000.01%
BAILARD, INC. 38,600$150,0000.01%
Chicago Partners Investment Group LLC 14,081$52,0000.01%
EXANE DERIVATIVES 4,078$15,863,0000.01%
View complete list of SATSUMA PHARMACEUTICALS INC shareholders